Our previous work has shown that the aptamer against the epithelial cell adhesion molecule (EpCAM) exhibited tumor penetration capacity in xenograft tumor tissue that was at least four-fold of that of the EpCAM antibody due to the smaller size of aptamers [8]. Here, EPCAM is linked to neoplasm.